Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies

Triple-negative breast cancer (TNBC), characterized by the absence or low expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor (HER2), is the most aggressive subtype of breast cancer. TNBC accounts for about 15% of breast cancer cases in the U....

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Gagan K., Collier, Amber L., Lee, Dasom, Hoefer, Richard A., Zheleva, Vasilena, Siewertsz van Reesema, Lauren L., Tang-Tan, Angela M., Guye, Mary L., Chang, David Z., Winston, Janet S., Samli, Billur, Jansen, Rick J., Petricoin, Emanuel F., Goetz, Matthew P., Bear, Harry D., Tang, Amy H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565566/
https://www.ncbi.nlm.nih.gov/pubmed/32846967
http://dx.doi.org/10.3390/cancers12092392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565566/
https://www.ncbi.nlm.nih.gov/pubmed/32846967
http://dx.doi.org/10.3390/cancers12092392

Ejemplares similares